Scilex Holding (SCLX) Operating Margin Growth (3y) (2025 - 2026)
Scilex Holding (SCLX) Operating Margin Growth (3y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 120.00 |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 531.00 |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 3,082.00 |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 842.00 |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | -95.00 |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | -347.00 |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -15,844.00 |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 20,333.00 |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | -2,411.00 |
| 10 | Scilex Holding | 39.35 Mn | -73.44 Mn | 3.97 Mn | -20,369.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,334.00 |
| Dec 31, 2025 | -212,962.00 |
| Sep 30, 2025 | -167,290.00 |
| Jun 30, 2025 | -6,250.00 |
| Mar 31, 2025 | -42,869.00 |